Stryker ROA 2006-2018 | SYK

Current and historical return on assets (ROA) values for Stryker (SYK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Stryker ROA for the three months ending September 30, 2018 was 12.26%.
Stryker ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.24B $22.08B 5.62%
2018-06-30 $1.08B $21.57B 4.94%
2018-03-31 $1.02B $22.13B 4.68%
2017-12-31 $1.02B $22.20B 4.77%
2017-09-30 $1.78B $21.49B 8.50%
2017-06-30 $1.70B $21.29B 8.25%
2017-03-31 $1.69B $20.52B 8.27%
2016-12-31 $1.65B $20.44B 8.15%
2016-09-30 $1.66B $20.19B 8.66%
2016-06-30 $1.61B $20.52B 8.88%
2016-03-31 $1.62B $19.67B 9.42%
2015-12-31 $1.44B $16.22B 8.78%
2015-09-30 $1.18B $15.92B 7.07%
2015-06-30 $0.93B $16.82B 5.47%
2015-03-31 $0.67B $16.58B 3.90%
2014-12-31 $0.52B $17.28B 3.02%
2014-09-30 $0.64B $17.52B 3.85%
2014-06-30 $0.69B $17.23B 4.29%
2014-03-31 $0.77B $16.16B 5.05%
2013-12-31 $1.01B $15.74B 6.81%
2013-09-30 $0.89B $14.88B 6.29%
2013-06-30 $1.14B $14.38B 8.37%
2013-03-31 $1.25B $14.09B 9.57%
2012-12-31 $1.30B $13.21B 10.24%
2012-09-30 $1.43B $12.78B 11.51%
2012-06-30 $1.40B $12.26B 11.46%
2012-03-31 $1.39B $12.46B 11.50%
2011-12-31 $1.35B $12.15B 11.43%
2011-09-30 $1.24B $12.08B 10.82%
2011-06-30 $1.25B $11.60B 11.23%
2011-03-31 $1.26B $11.23B 11.71%
2010-12-31 $1.27B $10.90B 12.17%
2010-09-30 $1.28B $10.77B 12.84%
2010-06-30 $1.18B $10.06B 12.48%
2010-03-31 $1.15B $10.10B 12.92%
2009-12-31 $1.11B $9.07B 13.40%
2009-09-30 $1.08B $8.46B 13.67%
2009-06-30 $1.12B $7.92B 14.65%
2009-03-31 $1.14B $7.59B 14.80%
2008-12-31 $1.15B $7.60B 14.85%
2008-09-30 $1.15B $7.58B 14.94%
2008-06-30 $1.10B $8.03B 14.70%
2008-03-31 $1.07B $7.75B 15.01%
2007-12-31 $1.02B $7.35B 15.25%
2007-09-30 $0.97B $6.86B 15.38%
2007-06-30 $0.93B $6.42B 15.63%
2007-03-31 $0.87B $6.08B 15.57%
2006-12-31 $0.78B $5.87B 14.56%
2006-09-30 $0.73B $5.40B 14.21%
2006-06-30 $0.66B $5.11B 13.56%
2006-03-31 $0.63B $4.99B 13.48%
2005-12-31 $0.64B $4.99B 14.61%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $62.695B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
Zimmer Biomet Holdings (ZBH) United States $21.487B 13.93
ResMed (RMD) United States $16.792B 32.02
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.90
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.85
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
BioLife Solutions (BLFS) United States $0.226B 305.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 18.07
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00